1Paczesny S, Ueno H, Fay J. Dendritic cells as vectors for im munotherapy of cancer. Semin Cancer Biol 2003 ; 13(6) :439-47.
2Ardavin C,Amigorena S, Reis Sousa C.Dendritic cells: immunobiology and cancer immunotherapy . Immunity 2004 ;20(1):17-23.
3Shimizu K, Fields RC, Giedlin M, et al. Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines. Proc Nall Acad Sci USA 1999;96(5) : 2268-2273.
4Buatois V, Baillet M, Becart S, et al. MHC class Ⅱ-pelnide complexes in dendritic cell lipid microomains initiate the CD4 Th1 phenotype. J Immunol 2003 ; 171 ( 11 ) :5812-5819.
